Literature DB >> 19033874

Clinical improvement in antiphospholipid syndrome after rituximab therapy.

Rosemary Adamson1, Shirish Sangle, Arvind Kaul, Graham R V Hughes, David P D'Cruz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19033874     DOI: 10.1097/RHU.0b013e31818f38d4

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN: 1076-1608            Impact factor:   3.517


× No keyword cloud information.
  6 in total

1.  Hughes syndrome (the antiphospholipid syndrome): a disease of our time.

Authors:  Graham R V Hughes
Journal:  Inflammopharmacology       Date:  2010-12-05       Impact factor: 4.473

2.  Management of antiphospholipid syndrome.

Authors:  Nicoletta Del Papa; Nikoleta Vaso
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-08       Impact factor: 5.346

Review 3.  Use of rituximab in the antiphospholipid syndrome.

Authors:  Deepak Kumar; Robert A S Roubey
Journal:  Curr Rheumatol Rep       Date:  2010-02       Impact factor: 4.592

Review 4.  Duration of anticoagulation treatment for thrombosis in APS: is it ever safe to stop?

Authors:  Sinthiya Punnialingam; Munther A Khamashta
Journal:  Curr Rheumatol Rep       Date:  2013-04       Impact factor: 4.592

Review 5.  An update on stem cell transplantation in autoimmune rheumatologic disorders.

Authors:  Sheryl Mascarenhas; Belinda Avalos; Stacy P Ardoin
Journal:  Curr Allergy Asthma Rep       Date:  2012-12       Impact factor: 4.806

6.  16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends.

Authors:  Hannah Cohen; Maria J Cuadrado; Doruk Erkan; Ali Duarte-Garcia; David A Isenberg; Jason S Knight; Thomas L Ortel; Anisur Rahman; Jane E Salmon; Maria G Tektonidou; David J Williams; Rohan Willis; Scott C Woller; Danieli Andrade
Journal:  Lupus       Date:  2020-10       Impact factor: 2.911

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.